J&J names Joaquin Duato as CEO effective January 3, replacing Alex Gorsky


Get real time updates directly on you device, subscribe now.

Joaquin Duato, executive vice president and worldwide chairman of pharmaceuticals at Johnson & Johnson on Tuesday, Jan. 31, 2017.

Andrew Harrer | Bloomberg | Getty Images

Johnson & Johnson announced Thursday evening that Joaquin Duato will become the company’s new CEO effective January 3, replacing current chairman and CEO Alex Gorsky.

Duato will be appointed as a member of the company’s Board of Directors following his transition to CEO.

“It has been an honor and privilege to lead this company as Chairman and CEO for nearly a decade, and I am pleased to serve as Executive Chairman to help oversee Johnson & Johnson’s ongoing progress improving the health of people and communities everywhere,” the company wrote in a statement.

Vials labelled “COVID-19 Coronavirus Vaccine” and syringe are seen in front of displayed Johnson & Johnson logo in this illustration taken, February 9, 2021.

Dado Ruvic | Reuters

This is breaking news. Please check back for updates.

Source link

You might also like
Leave A Reply

Your email address will not be published.